Synopsis
Synopsis
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 1-((4-biphenylyl)-phenylmethyl)-1h-imidazole
2. Amycor
3. Bay H 4502
4. Bay H-4502
5. Bifokey
6. Bifomyk
7. Bifon
8. Moldina
9. Mycospor
1. 60628-96-8
2. Mycospor
3. Trifonazole
4. Bifonazol
5. Bay H 4502
6. Amycor
7. Azolmen
8. Bifonazol [inn-spanish]
9. Bifonazolum [inn-latin]
10. 1-[phenyl-(4-phenylphenyl)methyl]imidazole
11. Bay H-4502
12. 1-((4-biphenylyl)phenylmethyl)-1h-imidazole
13. 1-(alpha-(4-biphenylyl)benzyl)imidazole
14. (+-)-1-(p,alpha-diphenylbenzyl)imidazole
15. Bay-h-4502
16. 1h-imidazole, 1-([1,1'-biphenyl]-4-ylphenylmethyl)-
17. 1-(p,alpha-diphenylbenzyl)imidazole
18. D01ac10
19. 1-([1,1'-biphenyl]-4-yl(phenyl)methyl)-1h-imidazole
20. Nsc-758954
21. Mls000028576
22. Chembl277535
23. Qyj305z91o
24. Bifonazolum
25. Chebi:78692
26. 1-[biphenyl-4-yl(phenyl)methyl]-1h-imidazole
27. 1h-imidazole, 1-((1,1'-biphenyl)-4-ylphenylmethyl)-
28. (+-)1-([1,1'-biphenyl]-4-ylphenylmethyl)-1h-imidazole
29. Ncgc00018254-03
30. Smr000058970
31. 1-[biphenyl-4-yl(phenyl)methyl]imidazole
32. Dsstox_cid_25631
33. Dsstox_rid_81013
34. Dsstox_gsid_45631
35. Mycospor (tn)
36. Cas-60628-96-8
37. (+/-)-bifonazole
38. Sr-01000003136
39. Einecs 262-336-6
40. 1-(biphenyl-4-yl(phenyl)methyl)-1h-imidazole
41. Brn 0618427
42. Unii-qyj305z91o
43. Mycosporan
44. Bedriol
45. Bifonazole,(s)
46. Bifonazole [usan:inn:ban:jan]
47. Mfcd00865567
48. Cpd000058970
49. Bifonazole [mi]
50. Bifonazole [inn]
51. Bifonazole [jan]
52. Opera_id_1656
53. Spectrum2_000035
54. Spectrum3_001970
55. (.+/-.)-bifonazole
56. Bifonazole [usan]
57. Imidazole, 1-(alpha-(4-biphenylyl)benzyl)-
58. 1-((4-biphenylyl)-phenylmethyl)-1h-imidazole
59. 1-(biphenyl-4-yl-phenyl-methyl)-1h-imidazole
60. Bifonazole [mart.]
61. Cid_2378
62. Bifonazole [who-dd]
63. Schembl36803
64. Bspbio_003570
65. 5-23-04-00292 (beilstein Handbook Reference)
66. Mls000759537
67. Mls001074074
68. Mls001424050
69. Spectrum1505309
70. Spbio_000129
71. Bifonazole (jp17/usan/inn)
72. Bifonazole [ep Impurity]
73. Bifonazole, >=98% (hplc)
74. Dtxsid9045631
75. Bifonazole For System Suitability
76. Kbio3_002922
77. Bifonazole [ep Monograph]
78. Hms1922b18
79. Hms2051f04
80. Hms2090k13
81. Hms2093b09
82. Hms2232j24
83. Hms3374h02
84. Hms3393f04
85. Hms3651g21
86. Hms3715l21
87. Pharmakon1600-01505309
88. 1h-imidazole, 1-((1,1'-biphenyl)-4-ylphenylmethyl)-, (+-)-
89. Amy32554
90. Bcp22297
91. Hy-b0301
92. Tox21_110850
93. Bdbm50128548
94. Ccg-39996
95. Dl-338
96. Nsc758954
97. S1854
98. Stk618771
99. Akos005553008
100. Tox21_110850_1
101. Ab07497
102. Bcp9000410
103. Ccg-100993
104. Db04794
105. Ks-5111
106. Nc00243
107. Nsc 758954
108. Mrf-0000274
109. Ncgc00018254-02
110. Ncgc00018254-04
111. Ncgc00018254-05
112. Ncgc00018254-08
113. Ncgc00018254-09
114. Ncgc00089815-02
115. Ncgc00089815-03
116. Ncgc00089815-04
117. Ac-15414
118. Bp164253
119. Sbi-0206755.p001
120. 1-(.alpha.-(4-biphenylyl)benzyl)imidazole
121. 1-(alpha,4-diphenylbenzyl)imidazole
122. 1-[alpha-(4-biphenylyl)-benzyl]-imidazole
123. (biphenyl-4-yl)-imidazol-1-yl-phenylmethane
124. B4173
125. Ft-0652733
126. Sw197623-3
127. Vu0239694-7
128. 1-[phenyl(4-phenylphenyl)methyl]-1h-imidazole
129. 28b968
130. D01775
131. Imidazole, 1-(.alpha.-(4-biphenylyl)benzyl)-
132. Ab00383029-16
133. Ab00383029_17
134. Ab00383029_18
135. (.+/-.)-1-(p,.alpha.-diphenylbenzyl)imidazole
136. A832816
137. Q421162
138. 1-(1-biphenyl-4-yl-2-phenyl-methyl)-1h-imidazole
139. Q-200717
140. Sr-01000003136-4
141. Sr-01000003136-6
142. (+/-)-1-(p,.alpha.-diphenylbenzyl)imidazole
143. 1-[phenyl-(4-phenylphenyl)methyl]imidazole;bifonazole
144. Brd-a94543220-001-02-3
145. Brd-a94543220-001-12-2
146. 1-(biphenyl-4-yl-phenyl-methyl)-1h-imidazole (bifonazole)
147. 1-(biphenyl-4-yl-phenyl-methyl)-1h-imidazole( Bifanozole)
148. 1-(biphenyl-4-yl-phenyl-methyl)-1h-imidazole(bifonazole)
149. 1-[[1,1'-biphenyl]-4-yl(phenyl)methyl]-1h-imidazole #
150. Bifonazole, European Pharmacopoeia (ep) Reference Standard
151. 1h-imidazole, 1-([1,1'-biphenyl]-4-ylphenylmethyl)-, (.+/-.)-
152. 1h-imidazole, 1-((1,1'-biphenyl)-4-ylphenylmethyl)-, (+/-)-
153. Bifonazole, Pharmaceutical Secondary Standard; Certified Reference Material
154. Bifonazole For System Suitability, European Pharmacopoeia (ep) Reference Standard
| Molecular Weight | 310.4 g/mol |
|---|---|
| Molecular Formula | C22H18N2 |
| XLogP3 | 4.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 4 |
| Exact Mass | 310.146998583 g/mol |
| Monoisotopic Mass | 310.146998583 g/mol |
| Topological Polar Surface Area | 17.8 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 362 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Used for the treatment of various topical fungal infections, including athlete's foot (tinea pedis).
Bifonazole is a type of antifungal medicine known as an imidazole. It kills fungi and yeasts by interfering with their cell membranes.
Antifungal Agents
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
D01AC10
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
D - Dermatologicals
D01 - Antifungals for dermatological use
D01A - Antifungals for topical use
D01AC - Imidazole and triazole derivatives
D01AC10 - Bifonazole
Absorption
Very low absorption following topical administration (0.6% of an applied dose). In cases of skin lesions absorption is increased (2.5%).
Hepatic.
1-2 hours
Bifonazole works by inhibiting the production of a substance called ergosterol, which is an essential component of fungal cell membranes.It acts to destabilize the fungal cyctochrome p450 51 enzyme (also known as Lanosterol 14-alpha demethylase). This is vital in the cell membrance structure of the fungus. Its inhibition leads to cell lysis. The disruption in production of ergosterol disrupts the cell membrane and causes holes to appear. The cell membranes of fungi are vital for their survival. They keep unwanted substances from entering the cells and stop the contents of the cells from leaking out. As bifonazole causes holes to appear in the cell membranes, essential constituents of the fungal cells can leak out. This kills the fungi.

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 2128-93-0
End Use API : Bifonazole
About The Company : Founded in 2006, ChemExpress specializes in offering CRO & CDMO services for pharmaceutical and biotech companies, focusing on small molecules, biologics and ne...
CAS Number : 7598-80-3
End Use API : Bifonazole
About The Company : Founded in 2006, ChemExpress specializes in offering CRO & CDMO services for pharmaceutical and biotech companies, focusing on small molecules, biologics and ne...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Mycosporan
Dosage Form : Cream
Dosage Strength : 1%
Packaging :
Approval Date : 13/06/1985
Application Number : 19850613000045
Regulatory Info : Deregistered
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Canesmycospor Onicoset
Dosage Form : Pomade
Dosage Strength : 10MG; 400 MG
Packaging :
Approval Date : 1995-06-01
Application Number : 59748
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Canesmycospor
Dosage Form : Cream
Dosage Strength : 10MG
Packaging :
Approval Date : 1987-06-01
Application Number : 57303
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Canespie Bifonazole
Dosage Form : Solution For Skin Spray
Dosage Strength : 10MG
Packaging :
Approval Date : 1987-06-01
Application Number : 57304
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Canespie Bifonazole
Dosage Form : Cream
Dosage Strength : 10MG
Packaging :
Approval Date : 2011-09-02
Application Number : 74651
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Levelina
Dosage Form : Cream
Dosage Strength : 10MG
Packaging :
Approval Date : 1990-09-01
Application Number : 58476
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Levelina
Dosage Form : Skin Powder
Dosage Strength : 10MG
Packaging :
Approval Date : 1990-09-01
Application Number : 58479
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Levelina
Dosage Form : Solution For Skin Spray
Dosage Strength : 10MG
Packaging :
Approval Date : 1990-09-01
Application Number : 58478
Regulatory Info : Authorized
Registration Country : Spain

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Cream
Dosage Strength : 1.0%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Cream
Dosage Strength : 1.0%
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Gel
Dosage Strength : 1%
Packaging : 10g
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 10g
Regulatory Info :
Dosage : Gel
Dosage Strength : 1%
Brand Name :
Approval Date :
Application Number :
Registration Country : China

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Gel
Dosage Strength : 1%
Packaging : 30g
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 30g
Regulatory Info :
Dosage : Gel
Dosage Strength : 1%
Brand Name :
Approval Date :
Application Number :
Registration Country : China

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generics
Registration Country : Costa Rica
Brand Name : Bifonazol CHEMO®
Dosage Form : CREAM
Dosage Strength : 1%
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generics
Registration Country : Costa Rica

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info : Generics
Dosage : CREAM
Dosage Strength : 1%
Brand Name : Bifonazol CHEMO®
Approval Date :
Application Number :
Registration Country : Costa Rica

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Israel
Brand Name : BIFOVIT
Dosage Form : Topical
Dosage Strength : 15G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Israel

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Topical
Dosage Strength : 15G
Brand Name : BIFOVIT
Approval Date :
Application Number :
Registration Country : Israel

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
14
PharmaCompass offers a list of Bifonazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bifonazole manufacturer or Bifonazole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bifonazole manufacturer or Bifonazole supplier.
PharmaCompass also assists you with knowing the Bifonazole API Price utilized in the formulation of products. Bifonazole API Price is not always fixed or binding as the Bifonazole Price is obtained through a variety of data sources. The Bifonazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bifomyk manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bifomyk, including repackagers and relabelers. The FDA regulates Bifomyk manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bifomyk API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bifomyk manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bifomyk supplier is an individual or a company that provides Bifomyk active pharmaceutical ingredient (API) or Bifomyk finished formulations upon request. The Bifomyk suppliers may include Bifomyk API manufacturers, exporters, distributors and traders.
click here to find a list of Bifomyk suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bifomyk DMF (Drug Master File) is a document detailing the whole manufacturing process of Bifomyk active pharmaceutical ingredient (API) in detail. Different forms of Bifomyk DMFs exist exist since differing nations have different regulations, such as Bifomyk USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bifomyk DMF submitted to regulatory agencies in the US is known as a USDMF. Bifomyk USDMF includes data on Bifomyk's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bifomyk USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bifomyk suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Bifomyk Drug Master File in Japan (Bifomyk JDMF) empowers Bifomyk API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Bifomyk JDMF during the approval evaluation for pharmaceutical products. At the time of Bifomyk JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Bifomyk suppliers with JDMF on PharmaCompass.
A Bifomyk CEP of the European Pharmacopoeia monograph is often referred to as a Bifomyk Certificate of Suitability (COS). The purpose of a Bifomyk CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Bifomyk EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Bifomyk to their clients by showing that a Bifomyk CEP has been issued for it. The manufacturer submits a Bifomyk CEP (COS) as part of the market authorization procedure, and it takes on the role of a Bifomyk CEP holder for the record. Additionally, the data presented in the Bifomyk CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Bifomyk DMF.
A Bifomyk CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Bifomyk CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Bifomyk suppliers with CEP (COS) on PharmaCompass.
A Bifomyk written confirmation (Bifomyk WC) is an official document issued by a regulatory agency to a Bifomyk manufacturer, verifying that the manufacturing facility of a Bifomyk active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bifomyk APIs or Bifomyk finished pharmaceutical products to another nation, regulatory agencies frequently require a Bifomyk WC (written confirmation) as part of the regulatory process.
click here to find a list of Bifomyk suppliers with Written Confirmation (WC) on PharmaCompass.
Bifomyk Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bifomyk GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bifomyk GMP manufacturer or Bifomyk GMP API supplier for your needs.
A Bifomyk CoA (Certificate of Analysis) is a formal document that attests to Bifomyk's compliance with Bifomyk specifications and serves as a tool for batch-level quality control.
Bifomyk CoA mostly includes findings from lab analyses of a specific batch. For each Bifomyk CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bifomyk may be tested according to a variety of international standards, such as European Pharmacopoeia (Bifomyk EP), Bifomyk JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bifomyk USP).